Chengfu Xu
- Epidemiology top 1%
- Molecular Biology top 10%
- Endocrinology, Diabetes and Metabolism top 1%
- Surgery top 5%
- Pathology and Forensic Medicine top 1%
- Topics
- Liver Disease Diagnosis and Treatment (91 papers)Diet, Metabolism, and Disease (26 papers)Alcohol Consumption and Health Effects (26 papers)
- Cited by
- NephrologyHepatologyEpidemiology
- Partner nations
- ChinaUnited StatesFrance
In The Last Decade
Chengfu Xu
169 papers receiving 4.8k citations
Hit Papers
Peers
Comparison fields: 5 of 135
- Epidemiology 2.5k
- Molecular Biology 1.1k
- Endocrinology, Diabetes and Metabolism 1.0k
- Surgery 913
- Pathology and Forensic Medicine 873
Countries citing papers authored by Chengfu Xu
This map shows the geographic impact of Chengfu Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chengfu Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chengfu Xu more than expected).
Fields of papers citing papers by Chengfu Xu
This network shows the impact of papers produced by Chengfu Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chengfu Xu. The network helps show where Chengfu Xu may publish in the future.
Co-authorship network of co-authors of Chengfu Xu
This figure shows the co-authorship network connecting the top 25 collaborators of Chengfu Xu. A scholar is included among the top collaborators of Chengfu Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chengfu Xu. Chengfu Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 2 | |
| 4 | 2 | |
| 5 | 11 | |
| 6 | 1 | |
| 7 | 3 | |
| 8 | 12 | |
| 9 | 6 | |
| 10 | 15 | |
| 11 | 3 | |
| 12 | 22 | |
| 13 | 4 | |
| 14 | 19 | |
| 15 | 9 | |
| 16 | 6 | |
| 17 | 25 | |
| 18 | 10 | |
| 19 | 13 | |
| 20 | Clinical features and prognostic factors of chronic glomerulonephritis with malignant hypertension | 4 |
About Chengfu Xu
Chengfu Xu is a scholar working on Hepatology, Gastroenterology and Epidemiology, having authored 183 papers that have together received 4.9k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (91 papers), Diet, Metabolism, and Disease (26 papers) and Alcohol Consumption and Health Effects (26 papers). The work is most often cited by research in Nephrology (691 citations), Hepatology (684 citations) and Epidemiology (2.5k citations). Chengfu Xu has collaborated with scholars based in China, United States and France. Frequent co-authors include Chaohui Yu, Youming Li, Lei Xu, Min Miao, Youming Li, Xingyong Wan, Hangkai Huang, Han Ma, Shenghui Chen and Yiming Lin. Their work appears in journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.